Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Market Dynamix™ is an independent, data-driven service focused on understanding the evolving dynamics of specialty markets poised for disruption. Leveraging quantitative and qualitative research, the ...
Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
Argenx has filed for FDA approval of subcutaneous efgartigimod, keeping it on track to start selling the sibling of its existing intravenous generalized myasthenia gravis (gMG) treatment Vyvgart. In ...
As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...
Eisai’s full-throttle development of a subcutaneous sibling to recently approved Alzheimer’s disease drug Leqembi could bear fruit in the coming quarters, with the Biogen-partnered drugmaker aiming to ...
Please provide your email address to receive an email when new articles are posted on . A recent comparative analysis shed light on the differences between subcutaneous panniculitis-like T-cell ...
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...
When the Flat Belly Diet experts talk about belly fat, it's important to know that there are actually two different types: subcutaneous and visceral. Subcutaneous is best defined as the fat that you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback